1
|
Garza A: The Aging Population: The
Increasing Effects on Health Care. http://www.pharmacytimes.com/publications/issue/2016/january2016/the-aging-population-the-increasing-effects-on-health-careJanuary
19–2016
|
2
|
Alzheimer's Association, . 2017
Alzheimer's Disease Facts and Figures. http://www.alz.org/facts/August 18–2017
|
3
|
American Cancer Society Cancer Action
Network, . The Costs of Cancer. Addressing Patient Costs.
https://www.acscan.org/sites/default/files/Costs%20of%20Cancer%20-%20Final%20Web.pdfAugust
18–2017
|
4
|
Boulanger LM: Immune proteins in brain
development and synaptic plasticity. Neuron. 64:93–109. 2009.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Nisticò R, Salter E, Nicolas C, Feligioni
M, Mango D, Bortolotto ZA, Gressens P, Collingridge GL and Peineau
S: Synaptoimmunology-roles in health and disease. Mol Brain.
10:262017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gomez CR, Nomellini V, Faunce DE and
Kovacs EJ: Innate immunity and aging. Exp Gerontol. 43:718–728.
2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zanussi S, Serraino D, Dolcetti R,
Berretta M and De Paoli P: Cancer, aging and immune reconstitution.
Anticancer Agents Med Chem. 13:1310–1324. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pera A, Campos C, López N, Hassouneh F,
Alonso C, Tarazona R and Solana R: Immunosenescence: Implications
for response to infection and vaccination in older people.
Maturitas. 82:50–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Ma Y and Fang M: Immunosenescence and
age-related viral diseases. Sci China Life Sci. 56:399–405. 2013.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Lotzová E, Savary CA, Freedman RS and
Bowen JM: Natural killer cell cytotoxic potential of patients with
ovarian carcinoma and its modulation with virus-modified tumor cell
extract. Cancer Immunol Immunother. 17:124–129. 1984. View Article : Google Scholar : PubMed/NCBI
|
11
|
Moretta L, Bottino C, Pende D, Mingari MC,
Biassoni R and Moretta A: Human natural killer cells: Their origin,
receptors and function. Eur J Immunol. 32:1205–1211. 2002.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Chretien AS, Le Roy A, Vey N, Prebet T,
Blaise D, Fauriat C and Olive D: Cancer-induced alterations of
NK-mediated target recognition: Current and investigational
pharmacological strategies aiming at restoring NK-mediated
anti-tumor activity. Front Immunol. 5:1222014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ivarsson MA, Michaëlsson J and Fauriat C:
Activating killer cell Ig-like receptors in health and disease.
Front Immunol. 5:1842014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ghoneum M: Anti-HIV activity in vitro of
MGN-3, an activated arabinoxylane from rice bran. Biochem Biophys
Res Commun. 243:25–29. 1998. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ghoneum M and Jewett A: Production of
tumor necrosis factor-alpha and interferon-gamma from human
peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from
rice bran, and its synergy with interleukin-2 in vitro. Cancer
Detect Prev. 24:314–324. 2000.PubMed/NCBI
|
16
|
Ghoneum M and Gollapudi S: Modified
arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell
leukemia cells to death receptor (CD95)-induced apoptosis. Cancer
Lett. 201:41–49. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Badr El-Din NK, Noaman E and Ghoneum M: In
vivo tumor inhibitory effects of nutritional rice bran supplement
MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutr Cancer.
60:235–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ghoneum M and Agrawal S: Activation of
human monocyte-derived dendritic cells in vitro by the biological
response modifier arabinoxylan rice bran (MGN-3/Biobran). Int J
Immunopathol Pharmacol. 24:941–948. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cholujova D, Jakubikova J, Czako B,
Martisova M, Hunakova L, Duraj J, Mistrik M and Sedlak J: MGN-3
arabinoxylan rice bran modulates innate immunity in multiple
myeloma patients. Cancer Immunol Immunother. 62:437–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Ghoneum M, Badr El-Din NK, Ali DA and
El-Dein MA: Modified arabinoxylan from rice bran, MGN-3/biobran,
sensitizes metastatic breast cancer cells to paclitaxel in vitro.
Anticancer Res. 34:81–87. 2014.PubMed/NCBI
|
21
|
Ghoneum M: Enhancement of human natural
killer cell activity by modified arabinoxylane from rice bran
(MGN-3). Int J Immunothe. 14:89–99. 1998.
|
22
|
Alter G, Malenfant JM and Altfeld M:
CD107a as a functional marker for the identification of natural
killer cell activity. J Immunol Methods. 294:15–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Ooi SL, McMullen D, Golombick T, Nut D and
Pak SC: Evidence-based review of BioBran/MGN-3 arabinoxylan
compound as a complementary therapy for conventional cancer
treatment. Integr Cancer Ther. Oct 1–2017.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
24
|
Ghoneum M and Brown J: NK
immunorestoration of cancer patients by MGN-3, a modified
arabinoxylan rice bran (study of 32 patients followed for up to 4
years)Wheat and rice in disease prevention and health. Anti-aging
medical therapeutics. Klatz R and Goldman R: III. Health Quest
Publications; Marina del Rey, CA: pp. 217–226. 1999
|
25
|
Ghoneum M and Abedi S: Enhancement of
natural killer cell activity of aged mice by modified arabinoxylan
rice bran (MGN-3/Biobran). J Pharm Pharmacol. 56:1581–1588. 2004.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Pérez-Martínez A, Valentín J, Fernández L,
Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz
F, Martín IG, Sallis H, et al: Arabinoxylan rice bran
(MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity
against neuroblastoma in vitro and in vivo. Cytotherapy.
17:601–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Ghoneum M: From bench to bedside: The
growing use of arabinoxylan rice bran (MGN-3/Biobran) in cancer
immunotherapy. Austin Immunol. 1:10062016.
|
28
|
Ogata K, An E, Shioi Y, Nakamura K, Luo S,
Yokose N, Minami S and Dan K: Association between natural killer
cell activity and infection in immunologically normal elderly
people. Clin Exp Immunol. 124:392–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
29
|
Smetana K Jr, Lacina L, Szabo P,
Dvořánková B, Brož P and Šedo A: Ageing as an important risk factor
for cancer. Anticancer Res. 36:5009–5017. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Ghoneum M, Suzuki K and Gollapudi S:
Phorbol myristate acetate corrects impaired NK function of old
mice. Scand J Immunol. 34:391–397. 1991. View Article : Google Scholar : PubMed/NCBI
|
31
|
Mariani E, Sgobbi S, Meneghetti A,
Tadolini M, Tarozzi A, Sinoppi M, Cattini L and Facchini A:
Perforins in human cytolytic cells: The effect of age. Mech Ageing
Dev. 92:195–209. 1996. View Article : Google Scholar : PubMed/NCBI
|
32
|
Rukavina D, Laskarin G, Rubesa G, Strbo N,
Bedenicki I, Manestar D, Glavas M, Christmas SE and Podack ER:
Age-related decline of perforin expression in human cytotoxic T
lymphocytes and natural killer cells. Blood. 92:2410–2420.
1998.PubMed/NCBI
|
33
|
Chng WJ, Tan GB and Kuperan P:
Establishment of adult peripheral blood lymphocyte subset reference
range for an asian population by single-platform flow cytometry:
Influence of age, sex, and race and comparison with other published
studies. Clin Diagn Lab Immunol. 11:168–173. 2004.PubMed/NCBI
|
34
|
Wang WS, Lo AW, Siu LP, Leung JN, Tu SP,
Tai SW, Lam SC and Wong KF: Reference ranges for lymphocyte subsets
among healthy Hong Kong Chinese adults by single-platform flow
cytometry. Clin Vaccine Immunol. 20:602–606. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Al-Mawali A, Pinto AD, Busaidi RA and
Al-Zakwani I: Lymphocyte subsets: Reference ranges in an age- and
gender-balanced population of Omani healthy adults. Cytometry A.
83:739–744. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Krzewski K, Gil-Krzewska A, Nguyen V,
Peruzzi G and Coligan JE: LAMP1/CD107a is required for efficient
perforin delivery to lytic granules and NK-cell cytotoxicity.
Blood. 121:4672–4683. 2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Aktas E, Kucuksezer UC, Bilgic S, Erten G
and Deniz G: Relationship between CD107a expression and cytotoxic
activity. Cell Immunol. 254:149–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Sun JC and Lanier LL: Natural killer cells
remember: An evolutionary bridge between innate and adaptive
immunity? Eur J Immunol. 39:2059–2064. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Godfrey DI, Hammond KJ, Poulton LD, Smyth
MJ and Baxter AG: NKT cells: Facts, functions and fallacies.
Immunol Today. 21:573–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
40
|
Brigl M and Brenner MB: CD1: Antigen
presentation and T cell function. Annu Rev Immunol. 22:817–890.
2004. View Article : Google Scholar : PubMed/NCBI
|
41
|
Shin JH and Park SH: The effect of
intracellular trafficking of CD1d on the formation of TCR
repertoire of NKT cells. BMB Rep. 47:241–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
42
|
Nisticò R, Pignatelli M, Piccinin S,
Mercuri NB and Collingridge G: Targeting synaptic dysfunction in
Alzheimer's disease therapy. Mol Neurobiol. 46:572–587. 2012.
View Article : Google Scholar : PubMed/NCBI
|
43
|
Pignatelli M, Feligioni M, Piccinin S,
Molinaro G, Nicoletti F and Nisticò R: Synaptic plasticity as a
therapeutic target in the treatment of autism-related single-gene
disorders. Curr Pharm Des. 19:6480–6490. 2013. View Article : Google Scholar : PubMed/NCBI
|
44
|
Nisticò R, Mori F, Feligioni M, Nicoletti
F and Centonze D: Synaptic plasticity in multiple sclerosis and in
experimental autoimmune encephalomyelitis. Philos Trans R Soc Lond
Ser B Biol Sci. 369:201301622013. View Article : Google Scholar
|
45
|
Musumeci G, Castrogiovanni P, Szychlinska
MA, Imbesi R, Loreto C, Castorina S and Giunta S: Protective
effects of high Tryptophan diet on aging-induced passive avoidance
impairment and hippocampal apoptosis. Brain Res Bull. 128:76–82.
2017. View Article : Google Scholar : PubMed/NCBI
|
46
|
Puzzo D, Staniszewski A, Deng SX,
Privitera L, Leznik E, Liu S, Zhang H, Feng Y, Palmeri A, Landry DW
and Arancio O: Phosphodiesterase 5 inhibition improves synaptic
function, memory, and amyloid-beta load in an Alzheimer's disease
mouse model. J Neurosci. 29:8075–8086. 2009. View Article : Google Scholar : PubMed/NCBI
|
47
|
Salama H, Medhat E, Shaheen M, Zekri AN,
Darwish T and Ghoneum M: Arabinoxylan rice bran (Biobran)
suppresses the viremia level in patients with chronic HCV
infection: A randomized trial. Int J Immunopathol Pharmacol.
29:647–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
48
|
Daiwa Pharmaceutical and Co., Ltd., .
BioBran rice bran arabinoxylan compound. http://www.daiwa-pharm.com/english/product/biobran.htmlOctober
22–2017
|
49
|
Tazawa K: BioBran/MGN-3: Basic and
Clinical Application to Integrative Medicine. Iyakushuppan Co.
Publishers; Tokyo: pp. 18–22. 2003
|
50
|
Takahara K and Sano K: The life
prolongation and QOL improvement effect of rice bran arabinoxylan
derivative (MGN-3, Bio-Bran) for progressive cancer. Clin Pharmacol
Therapy. 14:267–271. 2004.
|
51
|
Hajto T, Horvath A and Papp S: Improvement
of quality of life in tumor patients after an immunomodulatory
treatment with standardized mistletoe lectin and arabinoxylan plant
extracts. Int J Neurorehabilitation. 3:1–3. 2016. View Article : Google Scholar
|
52
|
Shimotoyodome A, Suzuki J, Kameo Y and
Hase T: Dietary supplementation with hydroxypropyl-distarch
phosphate from waxy maize starch increases resting energy
expenditure by lowering the postprandial glucose-dependent
insulinotropic polypeptide response in human subjects. Br J Nutr.
106:96–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
53
|
Hood LF, Vancampen DR, House WA and
Szatkowski E: Effect of modified and unmodified tapioca starches on
59Fe retention in rats. J Nutr. 106:1768–1772. 1976. View Article : Google Scholar : PubMed/NCBI
|
54
|
Kishida T, Nakai Y and Ebihara K:
Hydroxypropyl-distarch phosphate from Tapioca starch reduces zinc
and iron absorption, but not calcium and magnesium absorption, in
rats. J Nutr. 131:294–300. 2001. View Article : Google Scholar : PubMed/NCBI
|